UBE2J1 is identified as a novel plasma cell-related gene involved in the prognosis of high-grade serous ovarian cancer
Abstract Background Immune cells within tumor tissues play important roles in remodeling the tumor microenvironment, thus affecting tumor progression and the therapeutic response. The current study was designed to identify key markers of plasma cells and explore their role in high-grade serous ovari...
Saved in:
| Main Authors: | Yunjie Tian, Ruoyu Dong, Yingxia Guan, Ying Wang, Wei Zhao, Jun Zhang, Shan Kang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Journal of Translational Medicine |
| Online Access: | https://doi.org/10.1186/s12967-025-06135-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of fibroblast heterogeneity on prognosis and drug resistance in high-grade serous ovarian cancer
by: Tingjie Wang, et al.
Published: (2024-11-01) -
Risk Factors for Recurrence in Serous Borderline Ovarian Tumors and Early-Stage Low-Grade Serous Ovarian Carcinoma
by: Jingjing Zhang, et al.
Published: (2025-04-01) -
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer
by: Hao Huang, et al.
Published: (2024-12-01) -
RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer
by: Kyle C. Strickland, et al.
Published: (2025-08-01) -
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
by: Samar Elorbany, et al.
Published: (2024-11-01)